Aerie Pharmaceuticals
AERI
$15.25
Share price
0.00%
Change (1 day)
83.73%
Change (1 year)
Categories
EPS for Aerie Pharmaceuticals (AERI)
EPS in 2022 (TTM): -$0.75
According to Aerie Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$0.75. In 2021 the company made an earnings per share (EPS) of -$1.63.
EPS history for Aerie Pharmaceuticals from 2013 to 2022
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2022 (TTM) | -$0.75 | -53.99% |
| 2021 | -$1.63 | |
| 2019 | -$4.40 | -20.72% |
| 2018 | -$5.55 | 36.36% |
| 2017 | -$4.07 | 19.71% |
| 2016 | -$3.40 | 18.06% |
| 2015 | -$2.88 | 44% |
| 2014 | -$2.00 | 13.25% |
| 2013 | -$1.77 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Merck MRK | $1.82 | -342.89% | 🇺🇸 USA |
 Lexicon Pharmaceuticals
LXRX | -$0.68 | -9.33% | 🇺🇸 USA |
 Insmed INSM | -$5.27 | 602.67% | 🇺🇸 USA |